New kind of penis enlargement surgery will add inches, claims the doctor set to offer it... but there is a gruesome detail that may make some think twice

✕ Sensationalism: The headline uses sensational phrasing ('will add inches', 'gruesome detail') and appeals to curiosity and shock value, which is typical of tabloid framing. It overpromises on certainty ('will add') and includes emotionally charged language.

"New kind of penis enlargement surgery will add inches, claims the doctor set to offer it... but there is a gruesome detail that may make some think twice"

✕ Sensationalism: The lead paragraph opens with historical anecdotes involving snake bites and stone-tying, which sensationalizes the topic and frames modern medical inquiry within a primitive context, undermining seriousness.

"In 16th century Brazil, tribesmen reportedly allowed poisonous snakes to bite them in the belief it would increase their size. In Peru, some men tied stones to themselves in crude attempts at stretching."

✕ Loaded Language: The phrase 'gruesome detail' is emotionally charged and judgmental, shaping reader perception before any medical facts are presented.

"but there is a gruesome detail that may make some think twice"

✕ Loaded Language: Describing historical practices as 'crude attempts at stretching' uses dismissive, pejorative language that undermines cultural context and sets a mocking tone.

"In Peru, some men tied stones to themselves in crude attempts at stretching."

✕ Loaded Language: The use of 'manhood' and 'enhance their manhood' ties penis size to masculinity in a way that reinforces cultural anxieties rather than medical necessity.

"Men have searched for ways to enhance their manhood for centuries."

✕ Editorializing: The article quotes Dr Diamond’s promotional claim without challenge, allowing him to frame the procedure as pioneering and exciting without counterbalance.

"We are excited to use it in the penis and see how it works."

✕ Single-Source Reporting: The article relies almost entirely on Dr. Stuart Diamond as the primary source, with no independent urologists, ethicists, or FDA representatives offering commentary or critique.

"We are the first clinic in the US – in the world – to use this filler for this surgery,' Dr Diamond said."

✕ Vague Attribution: A Reddit user is quoted about complications, but their identity and medical verification are unconfirmed, introducing anecdotal risk without expert validation.

"One woman, posting on Reddit, claimed she had alloClae injected into both breasts to enhance their size, but later developed multiple cysts that were often painful."

✕ Vague Attribution: The American Urological Association is mentioned in passing, but no representative is quoted, limiting authoritative balance.

"according to the American Urological Association"

✓ Proper Attribution: The article includes proper attribution for the filler manufacturer (Tiger Aesthetics) and notes FDA approval for other uses, which adds some sourcing clarity.

"The procedure will use alloClae, an FDA-approved filler derived from donated human fat and manufactured by New Jersey company Tiger Aesthetics."

✕ Narrative Framing: The story is framed as a medical innovation frontier, focusing on novelty and potential benefit while downplaying ethical and safety scrutiny. It centers on the doctor’s ambition rather than patient need or public health implications.

"We are the first clinic in the US – in the world – to use this filler for this surgery,' Dr Diamond said."

✕ Framing by Emphasis: The article emphasizes the 'gruesome' aspect of using dead donor fat, turning a technical detail into a moral or emotional hook, which shifts focus from medical evaluation to sensational curiosity.

"but there is a gruesome detail that may make some think twice"

✓ Contextualisation: The article includes relevant historical context on penis enlargement attempts and explains the medical rationale behind fat transfer, off-label use, and risks like fat embolism and necrosis.

"Fat transfer procedures to enlarge the penis have existed for years, but they are expensive and time-consuming. Patients must first undergo liposuction so fat can be removed, processed and then reinjected into the penis."

✓ Contextualisation: It notes that the FDA has not approved any penis enlargement procedure and that using fillers for this purpose is off-label — a critical regulatory context.

"The FDA has never approved any procedure designed to increase penis size."

✓ Contextualisation: The article includes a patient-reported adverse outcome involving cysts from alloClae in breast augmentation, providing real-world risk context.

"One woman, posting on Reddit, claimed she had alloClae injected into both breasts to enhance their size, but later developed multiple cysts that were often painful."